Filing Details

CUSIP No.  76760R100

1	NAME OF REPORTING PERSON Lawrence W. Lepard
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (See Instructions) (a)   q (b)   q
3	SEC USE ONLY
4	SOURCE OF FUNDS (See Instructions) PF/AF
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  o
6	CITIZENSHIP OR PLACE OF ORGANIZATION United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER   9,037,500
		8	SHARED VOTING POWER 12,670,000
		9	SOLE DISPOSITIVE POWER   9,037,500
		10	SHARED DISPOSITIVE POWER 12,670,000
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON 21,707,500*
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)   o
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.5%**
14	TYPE OF REPORTING PERSON (See Instructions) IN

CUSIP No.  76760R100

1	NAME OF REPORTING PERSON EMA GARP FUND, LP
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (See Instructions) (a)   q (b)   q
3	SEC USE ONLY
4	SOURCE OF FUNDS (See Instructions) WC
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  o
6	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER 0
		8	SHARED VOTING POWER 11,620,000
		9	SOLE DISPOSITIVE POWER 0
		10	SHARED DISPOSITIVE POWER 11,620,000
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON 11,620,000*
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)    o
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.2%**
14	TYPE OF REPORTING PERSON (See Instructions) PN

CUSIP No.  76760R100

1	NAME OF REPORTING PERSON EMA GARP GP, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (See Instructions) (a)   q (b)   q
3	SEC USE ONLY
4	SOURCE OF FUNDS (See Instructions) AF
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)  q
6	CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		7	SOLE VOTING POWER 0
		8	SHARED VOTING POWER 11,620,000
		9	SOLE DISPOSITIVE POWER 0
		10	SHARED DISPOSITIVE POWER 11,620,000
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON 11,620,000*
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)    o
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.2%**
14	TYPE OF REPORTING PERSON (See Instructions) OO

Item 1.

Security and Issuer.

The name of the issuer is Rise Gold Corp., a Nevada corporation (Issuer), which has its principal executive offices at Suite 650, 669 Howe Street, Vancouver, British Columbia, Canada V6C 0B4. This report relates to the Issuers class of common stock without par value (Common Stock).

Item 2.

Identity and Background.

(a):

This Schedule 13D has been jointly filed by Lawrence W. Lepard, EMA GARP FUND, LP (the Fund), and EMA GARP GP, LLC (the GP). Each party filing the Schedule 13D is also referred to herein as a reporting person.  The GP is the general partner of the Fund. Mr. Lepard is the sole member and manager of the GP.

(b):

The address of each of the reporting persons is 211 Grove Street, Wellesley, Massachusetts 02482.

(c):

The Funds principal business is investing in securities. The GPs principal business is providing investment management for the Fund. Mr. Lepards principal business is acting as manager of the GP and providing investment management for the Fund.

(d):

During the last five years none of the reporting persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e):

During the last five years, none of the reporting persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in their being subject, either currently or in the past, to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f):

Mr. Lepard is citizen of the United States. The GP is a Delaware limited liability company. The Fund is a Delaware limited partnership.

Item 3.

Source and Amount of Funds or Other Consideration.

On August 19, 2019, Mr. Lepard purchased a total of 4,000,000 units (Units) from the Issuer in a private placement for C$0.07 per Unit (the Placement). In the Placement, each Unit consisted of one share of Common Stock and one-half warrant to buy Common Stock, with each whole warrant having an exercise price of C$0.10 per share and a term of three years. The aggregate purchase price of the Units was C$280,000. Mr. Lepard used his personal funds to pay for the Units.

On August 19, 2019, the Fund purchased a total of 5,000,000 Units from the Issuer in the Placement. The aggregate purchase price of the Units was C$350,000. The Fund used its working capital to pay for the Units.

As a result of these purchases, the reporting persons each acquired beneficial ownership of more than 5% of the class of Common Stock.

---

Item 4.

Purpose of Transaction.

The reporting persons purchased the Units for investment purposes. Following the purchase of the Units, Mr. Lepard was appointed as a director of the Issuer on August 22, 2019. The reporting persons intend to influence the policies of the Issuer with a goal of maximizing the value of the Common Stock.

As of the date hereof, and except as otherwise disclosed herein,the reporting persons do not have any plans or proposals which relate to or would result in:

(a)

The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer;

(b)

An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries;

(c)

A sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries;

(d)

Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board;

(e)

Any material change in the present capitalization or dividend policy of the Issuer;

(f)

Any other material change in the Issuer's business or corporate structure;

(g)

Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions that may impede the acquisition of control of the Issuer by any person;

(h)

Causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association;

(i)

A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to section 12(g)(4) of the Act; or

(j)

Any action similar to any of those enumerated above.

The reporting persons may purchase, sell or transfer Common Stock beneficially owned by them from time to time in public transactions depending on economic considerations. Any such transactions may be effected at any time or from time to time subject to any applicable limitations imposed on the sale of the Common Stock by applicable law.

Item 5.

Interest in Securities of the Issuer.

(a) (b)

As of the date of this report, Mr. Lepard beneficially owns a total of 21,707,500 shares of Common Stock, which is 9.5% of the class of Common Stock as calculated in accordance with Rule 13d-3 under the Securities Exchange Act of 1934. The Fund

---

Rule 13d-3 provides, in part, that shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option or warrant) within 60 days. In computing the percentage ownership of any person under Rule 13d-3, the amount of shares outstanding is deemed to include the number of shares beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of the person does not necessarily reflect a persons actual ownership or voting power with respect to the number of shares actually outstanding. The Issuer currently has a total of 220,459,647 shares of Common Stock outstanding.

All of the shares of Common Stock listed in the table below are currently beneficially owned by Mr. Lepard. In the table, the 7,320,000 shares held by the Fund and the 4,300,000 shares underlying warrants held by the Fund are also beneficially owned by the Fund and the GP.

Outstanding Shares	Shares Underlying Currently Exercisable Warrants or Options	Registered Holders
4,918,750(1)		Mr. Lepard
	2,818,750(1) (Underlying Warrants)	Mr. Lepard
	1,000,000(1) (Underlying Options)	Mr. Lepard
1,350,000(2)		IRAs of Mr. Lepards Three Children
7,320,000(3)		The Fund
	4,300,000(3) (Underlying Warrants)	The Fund

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

The information provided in Items 3, 4 and 5 is incorporated by reference in its entirety in this Item 6.

Item 7.

Material to be Filed as Exhibits.

The parties have entered into a Joint Filing Agreement dated September 3, 2019, which is attached as Exhibit A to this filing.

---

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this report is true, complete and correct.

Dated:  September 5, 2019

 /s/ Lawrence W. Lepard

   Lawrence W. Lepard

EMA GARP FUND, LP

By EMA GARP GP, LLC as General Partner

By:  /s/ Lawrence W. Lepard

Lawrence W. Lepard

Manager of EMA GARP GP, LLC

EMA GARP GP, LLC

By:  /s/ Lawrence W. Lepard

Lawrence W. Lepard

Manager

---

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the parties named below agree to the joint filing on behalf of each them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of Common Stock of Rise Gold Corp., a Nevada corporation, and further agree that this Joint Filing Agreement be included as Exhibit A to such Schedule 13D. In evidence thereof, the undersigned hereby execute this agreement this 3^rd day of September, 2019.

 /s/ Lawrence W. Lepard

   Lawrence W. Lepard

EMA GARP FUND, LP

By EMA GARP GP, LLC as General Partner

By:  /s/ Lawrence W. Lepard

Lawrence W. Lepard

Manager of EMA GARP GP, LLC

EMA GARP GP, LLC

By:  /s/ Lawrence W. Lepard

Lawrence W. Lepard

Manager